14h
ET Now on MSNCipla Q4 Results FY 2025 Date and Time: Dividend in upcoming board meeting – Check quarterly earnings announcement scheduleDrug major Cipla Ltd is the latest company to declare its schedule for the release of its earnings report for the fourth ...
Target enrollment achieved in RAPIDe-3, a pivotal Phase 3 study of deucrictibant for the on-demand treatment of HAE attacks, strengthening confidence in clinical timelinesEnrollment underway in ...
Ecolab's management targets 12%-15% EPS growth, but I find this overly optimistic. Read why I maintain my hold rating on ECL ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results